Insulin-like growth factor -I deficiency.

Abstract

The insulin-like growth factor (IGF) system composed of two ligands, their receptors and regulatory proteins (acid-labile subunit and IGF-binding proteins) plays a central role in the regulation of growth and development in mammals. In addition to its key role in the stimulation of cellular proliferation and growth, IGF-I has important effects on carbohydrate, protein and bone metabolism. The molecular biology and physiology of the IGF system are complex, resulting in many potential mechanisms of IGF deficiency. Briefly, IGF-I deficiency may result from a primary defect in the IGF-I gene, its promoters, or may be secondary to a defect outside the gene itself. It may also result as a consequence of growth hormone (GH) deficiency, GH receptor/post-receptor abnormalities or abnormalities of the IGF-I receptor. The purpose of this presentation is to review the different types of IGF-I deficiency using the well-characterized clinical conditions with its associated biochemical and molecular defects. The clinical consequences in terms of phenotype-genotype, linear growth and body composition in patients with primary and secondary IGF deficiency will be presented, together with results from recombinant human (rh)IGF-I replacement therapy. Finally, as primary IGF-I deficiency is associated with insulin resistance, some of the metabolic actions of IGF-I will be briefly discussed.

Statistics

05001000'04'06'08'10'12'14'16
Citations per Year

111 Citations

Semantic Scholar estimates that this publication has 111 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{CamachoHbner2001InsulinlikeGF, title={Insulin-like growth factor -I deficiency.}, author={Cecilia Camacho-H{\"{u}bner and Margaret Savage}, journal={Hormone research}, year={2001}, volume={55 Suppl 1}, pages={17-20} }